Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

ABMD - Abiomed Inc.


Close
381.02
0.230   0.060%

Share volume: 0
Last Updated: Wed 21 Dec 2022 10:00:01 PM CET
Surgical and Medical Instrument Manufacturing : -0.56%

PREVIOUS CLOSE
CHG
CHG%

$380.79
0.23
0.06%
This ticker is disabled and data are no longer maintained and up to date.
Fundamental analysis
76%
Profitability 99%
Dept financing 5%
Liquidity 75%
Performance 71%
Company vs Stock growth
vs
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$381.02
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$5.80
52 WEEK RANGE
$0.00 - $0.00
52 WEEK CHANGE
$0.00
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
45.091 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$0
AVERAGE 30 VOLUME 
$0
Company detail
CEO: Michael Minogue
Region: US
Website: www.abiomed.com
Employees: 1,725
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

Abiomed Europe GmbH, Aachen / Germany, as affiliate of Abiomed Inc. headquartered in Danvers, Massachusetts, USA, is a leading medical technology company in the field of circulatory support. Its products aim to enable heart recovery by improving blood circulation and/or heart pump function.

Recent news